検索結果 - Jean‐Jacques Body

結果の絞り込み
  1. 1
    Increased fracture rate in women with breast cancer: a review of the hidden risk

    Increased fracture rate in women with breast cancer: a review of the hidden risk 著者: Jean‐Jacques Body

    出版事項 2011
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  2. 2
    Breast Cancer: Bisphosphonate Therapy for Metastatic Bone Disease

    Breast Cancer: Bisphosphonate Therapy for Metastatic Bone Disease 著者: Jean‐Jacques Body

    出版事項 2006
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  3. 3
    Epinephrine is a Hypophosphatemic Hormone in Man. PHYSIOLOGICAL EFFECTS OF CIRCULATING EPINEPHRINE ON PLASMA CALCIUM, MAGNESIUM, PHOSPHORUS, PARATHYROID HORMONE, AND CALCITONIN

    Epinephrine is a Hypophosphatemic Hormone in Man. PHYSIOLOGICAL EFFECTS OF CIRCULATING EPINEPHRINE ON PLASMA CALCIUM, MAGNESIUM, PHOSPHORUS, PARATHYROID HORMONE, AND CALCITONIN 著者: Jean‐Jacques Body, Philip E. Cryer, Kenneth P. Offord, Hunter Heath

    出版事項 1983
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  4. 4
    Bone health in cancer patients: ESMO Clinical Practice Guidelines

    Bone health in cancer patients: ESMO Clinical Practice Guidelines 著者: Robert E. Coleman, Jean‐Jacques Body, Matti Aapro, Peyman Hadji, Jørn Herrstedt

    出版事項 2014
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  5. 5
    Management of bone health in solid tumours: From bisphosphonates to a monoclonal antibody

    Management of bone health in solid tumours: From bisphosphonates to a monoclonal antibody 著者: Roger von Moos, Luís Costa, Eva González‐Suárez, Evangelos Terpos, Daniela Niepel, Jean‐Jacques Body

    出版事項 2019
    全文の入手
    Revisão
    お気に入りに追加
    保存先:
  6. 6
    Updated guidance on the management of cancer treatment-induced bone loss (CTIBL) in pre- and postmenopausal women with early-stage breast cancer

    Updated guidance on the management of cancer treatment-induced bone loss (CTIBL) in pre- and postmenopausal women with early-stage breast cancer 著者: Komal Waqas, Joana Lima Ferreira, Elena Tsourdi, Jean‐Jacques Body, Peyman Hadji, M. Carola Zillikens

    出版事項 2021
    全文の入手
    Revisão
    お気に入りに追加
    保存先:
  7. 7
    Increased Dickkopf-1 expression in breast cancer bone metastases

    Increased Dickkopf-1 expression in breast cancer bone metastases 著者: Nathalie Voorzanger‐Rousselot, Delphine Goehrig, Fabrice Journé, Valérie Doriath, Jean‐Jacques Body, Philippe Clézardin, Patrick Garnero

    出版事項 2007
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  8. 8
    The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts

    The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts 著者: Hichame Id Boufker, Laurence Lagneaux, Mehdi Najar, Martine Piccart, Ghanem Ghanem, Jean‐Jacques Body, Fabrice Journé

    出版事項 2010
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  9. 9
    Systematic review and meta-analysis on the proportion of patients with breast cancer who develop bone metastases

    Systematic review and meta-analysis on the proportion of patients with breast cancer who develop bone metastases 著者: Jean‐Jacques Body, Geoffrey C. Quinn, Susan Talbot, Emma Booth, Gaston Demonty, Aliki Taylor, Justyna Amelio

    出版事項 2017
    全文の入手
    Revisão
    お気に入りに追加
    保存先:
  10. 10
    Bariatric surgery and skeletal health: A narrative review and position statement for management by the European Calcified Tissue Society (ECTS)

    Bariatric surgery and skeletal health: A narrative review and position statement for management by the European Calcified Tissue Society (ECTS) 著者: Julien Paccou, Elena Tsourdi, Christian Meier, Andrea Palermo, Jessica Pepe, Jean-Jacques Body, M. Carola Zillikens

    出版事項 2021
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  11. 11
    Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studies

    Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studie... 著者: Jean‐Jacques Body, Ingo Diel, M. Lichinitzer, A. F Lazarev, Martin Pecherstorfer, R. Bell, Debu Tripathy, B. Bergström

    出版事項 2004
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  12. 12
    Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS

    Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS 著者: Athanasios D. Anastasilakis, Jessica Pepe, Nicola Napoli, Andrea Palermo, Christos Magopoulos, Aliya Khan, M. Carola Zillikens, Jean-Jacques Body

    出版事項 2021
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  13. 13
    Which treatment to prevent an imminent fracture?

    Which treatment to prevent an imminent fracture? 著者: Laura, Iconaru, Felicia, Baleanu, Alexia, Charles, Aude, Mugisha, Florence, Benoit, Murielle, Surquin, Rafik, Karmali, Jean-Jacques, Body, Pierre, Bergmann

    出版事項 2021
    全文の入手 全文の入手 全文の入手
    テキスト
    お気に入りに追加
    保存先:
  14. 14
    Loading and Skeletal Development and Maintenance

    Loading and Skeletal Development and Maintenance 著者: P. Bergmann, Jean‐Jacques Body, S. Boonen, Y. Boutsen, J.-P. Devogelaer, Stefan Goemaere, JM Kaufman, Jean‐Yves Reginster, Serge Rozenberg

    出版事項 2010
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  15. 15
    A study of the biological receptor activator of nuclear factor-kappaB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer.

    A study of the biological receptor activator of nuclear factor-kappaB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer. 著者: Jean-Jacques Body, Thierry Façon, Robert E. Coleman, Allan Lipton, F. Geurs, Michelle Fan, Donna Holloway, Mark Peterson, Pirow Bekker

    出版事項 2006
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  16. 16
    Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases

    Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases 著者: Jean‐Jacques Body, Ingo Diel, М. Р. Личиницер, E.D. Kreuser, W. Dornoff, В. А. Горбунова, M. Budde, B. Bergström

    出版事項 2003
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  17. 17
    Randomized Phase II Trial of Denosumab in Patients With Bone Metastases From Prostate Cancer, Breast Cancer, or Other Neoplasms After Intravenous Bisphosphonates

    Randomized Phase II Trial of Denosumab in Patients With Bone Metastases From Prostate Cancer, Breast Cancer, or Other Neoplasms After Intravenous Bisphosphonates 著者: Karim Fizazi, Allan Lipton, Xavier Mariette, Jean‐Jacques Body, Yasmin Rahim, Julie R. Gralow, Guozhi Gao, Ling Wu, Winnie Sohn, Susie Jun

    出版事項 2009
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  18. 18
    Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Adults: Consensus Recommendations From the Belgian Bone Club

    Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Adults: Consensus Recommendations From the Belgian Bone Club 著者: Michaël R. Laurent, Stefan Goemaere, Charlotte Verroken, Pierre Bergmann, Jean‐Jacques Body, Olivier Bruyère, Étienne Cavalier, Serge Rozenberg, Bruno Lapauw, Evelien Gielen

    出版事項 2022
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  19. 19
    Tumor-Induced Osteomalacia: A Systematic Clinical Review of 895 Cases

    Tumor-Induced Osteomalacia: A Systematic Clinical Review of 895 Cases 著者: Ariadne Bosman, Andrea Palermo, Julien Vanderhulst, Suzanne M. Jan de Beur, Seiji Fukumoto, Salvatore Minisola, Weibo Xia, Jean‐Jacques Body, M. Carola Zillikens

    出版事項 2022
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  20. 20
    Role of bone and kidney in tumor-induced hypercalcemia and its treatment with bisphosphonate and sodium chloride

    Role of bone and kidney in tumor-induced hypercalcemia and its treatment with bisphosphonate and sodium chloride 著者: Hubertus I.J. Harinck, O. L. M. Bijvoet, AndréS.T. Plantingh, Jean‐Jacques Body, Jan Willem F. Elte, H.P. Sleeboom, J. Wildiers, Jan P. Neijt

    出版事項 1987
    全文の入手
    Artigo
    お気に入りに追加
    保存先:

検索ツール: